Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Planquette

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Frontiers in Medicine|December 7, 2020
Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular AfterloadGuillaume Goudot, Richard Chocron, Jean-Loup Augy, et al.
Thrombosis Research|February 3, 2024
Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trialSérine Chaibi, Pierre-Marie Roy, Armelle Arnoux Guénégou, et al.
The New England Journal of Medicine|December 22, 2016
Hypothermia for Neuroprotection in Convulsive Status EpilepticusStephane Legriel, Virginie Lemiale, Maleka Schenck, et al.
The European Respiratory Journal|January 6, 2018
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trialCécile Tromeur, Olivier Sanchez, Emilie Presles, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2021
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortalityDavid M Smadja, Aurélien Philippe, Olivier Bory, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Thrombosis and Haemostasis|February 10, 2022
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)Benjamin Planquette, Lina Khider, Alice Le Berre, et al.
Plos One|January 14, 2021
Impact of integrating objective structured clinical examination into academic student assessment: Large-scale experience in a French medical schoolAlexandre Matet, Ludovic Fournel, François Gaillard, et al.
Angiogenesis|January 15, 2021
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortalityAurélien Philippe, Richard Chocron, Nicolas Gendron, et al.
Immunity & Ageing : I & A|May 7, 2024
Increased levels of GM-CSF and CXCL10 and low CD8<sup>+</sup> memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older peopleJohanne Poisson, Carine El-Sissy, Arnaud Serret-Larmande, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Frontiers in Medicine|December 7, 2020
Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular AfterloadGuillaume Goudot, Richard Chocron, Jean-Loup Augy, et al.
Thrombosis Research|February 3, 2024
Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trialSérine Chaibi, Pierre-Marie Roy, Armelle Arnoux Guénégou, et al.
The New England Journal of Medicine|December 22, 2016
Hypothermia for Neuroprotection in Convulsive Status EpilepticusStephane Legriel, Virginie Lemiale, Maleka Schenck, et al.
The European Respiratory Journal|January 6, 2018
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trialCécile Tromeur, Olivier Sanchez, Emilie Presles, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2021
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortalityDavid M Smadja, Aurélien Philippe, Olivier Bory, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Thrombosis and Haemostasis|February 10, 2022
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)Benjamin Planquette, Lina Khider, Alice Le Berre, et al.
Plos One|January 14, 2021
Impact of integrating objective structured clinical examination into academic student assessment: Large-scale experience in a French medical schoolAlexandre Matet, Ludovic Fournel, François Gaillard, et al.
Angiogenesis|January 15, 2021
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortalityAurélien Philippe, Richard Chocron, Nicolas Gendron, et al.
Immunity & Ageing : I & A|May 7, 2024
Increased levels of GM-CSF and CXCL10 and low CD8<sup>+</sup> memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older peopleJohanne Poisson, Carine El-Sissy, Arnaud Serret-Larmande, et al.
Pageof 11